Skip to main content
Earnings Labs
Traws Pharma, Inc. logo

Traws Pharma, Inc. (TRAW)

NASDAQ·Healthcare·Biotechnology

$0.35

-4.34%

Mkt Cap $6.78M

Analyst Ratings

Buy

1

Hold

3

Sell

0

Price Target (2 analysts)

$1.00

Range $1.00 – $1.00

Implied Upside

+185.6%

Consensus $1.00 vs current $0.35